Infectious Disease and Microbiology – Ureaplasma urealyticum and Ureaplasma parvum

Overview

Ureaplasma urealyticum and Ureaplasma parvum are extremely small bacteria belonging to the group of organisms that lack a cell wall. They commonly colonize the human genitourinary tract and may be associated with nongonococcal urethritis, pregnancy-related infections such as chorioamnionitis, and invasive infection in newborns.

Because Ureaplasma lacks a cell wall, antibiotics that act on bacterial cell-wall synthesis, such as penicillins and cephalosporins, are intrinsically ineffective.

Classification

Genus: Ureaplasma

Important species:

• Ureaplasma urealyticum

• Ureaplasma parvum

Organism: Very small bacterium without a cell wall

Microbiologic Characteristics

Ureaplasma organisms are:

• Extremely small

• Cell-wall deficient

• Pleomorphic

• Poorly visualized by routine Gram staining

• Capable of colonizing the genitourinary tract

• Dependent on specialized culture conditions

They are closely related to:

Mycoplasma

No Cell Wall

The single most important microbiologic feature is:

UREAPLASMA HAS NO CELL WALL

Therefore, it lacks the usual:

Peptidoglycan layer

found in most bacteria.

Antibiotic Consequence

Because there is no cell wall:

β-lactam antibiotics have no target.

Therefore:

• Penicillin → ineffective

• Amoxicillin → ineffective

• Cephalosporins → ineffective

• Carbapenems → ineffective

This is an important examination point.

High-Yield Microbiology Pattern

Very small bacterium

• ●

No cell wall

• ●

Genitourinary tract

• ●

Urethritis

→ Think UREAPLASMA

Urease Activity

The name Ureaplasma reflects an important metabolic characteristic:

UREA HYDROLYSIS

These organisms possess:

Urease

and use urea as an important metabolic substrate.

This feature helps distinguish Ureaplasma from many Mycoplasma species.

Memory Aid

UREA-plasma → UREA → UREASE

Incubation Period

For sexually acquired nongonococcal urethritis associated with U. urealyticum, the source gives an incubation period of approximately:

10–20 DAYS

Epidemiology

Ureaplasma species occur:

Worldwide

They frequently colonize the:

Lower genitourinary tract

without producing symptoms.

Therefore, detection of Ureaplasma does not always mean that it is responsible for a patient’s disease.

Colonization vs. Infection

This distinction is particularly important.

Ureaplasma may be present in healthy individuals as:

Asymptomatic colonizing flora

Therefore:

Positive test ≠ automatically active infection

Clinical findings and the site of detection must be considered when determining whether the organism is clinically significant.

Transmission

Transmission can occur through:

Sexual contact

and from mother to infant through:

Vertical/perinatal transmission

Maternal genital colonization can therefore be important in pregnancy and neonatal disease.

Nongonococcal Urethritis

One of the infections associated with U. urealyticum is:

NONGONOCOCCAL URETHRITIS (NGU)

Possible manifestations include:

• Dysuria

• Urethral discomfort

• Urethral discharge

• Urethral irritation

However, other organisms—particularly Chlamydia trachomatis and Mycoplasma genitalium—are also important causes of NGU.

High-Yield Clinical Pattern

Sexual exposure

• ●

10–20 days

• ●

Urethritis

• ●

No gonococcal infection identified

→ Consider Ureaplasma urealyticum

Pregnancy-Associated Infection

Ureaplasma species may be associated with infections involving:

Pregnancy and the fetal membranes

The source specifically identifies:

CHORIOAMNIONITIS

Chorioamnionitis

Chorioamnionitis is infection and inflammation involving the:

Chorion and amnion

Ureaplasma can ascend from the maternal genital tract and may participate in:

Intra-amniotic infection and inflammation

Neonatal Infection

The source also identifies:

DISSEMINATED INFECTION IN THE NEWBORN

Neonates, particularly premature infants, may be vulnerable to invasive infection because of:

Immature host defenses

Other Neonatal Associations

Depending on the clinical setting, Ureaplasma has also been associated with:

• Respiratory tract colonization/infection

• Pneumonia

• Bacteremia

• Meningitis

Premature infants represent an especially important susceptible population.

High-Yield Neonatal Pattern

Maternal genital colonization/infection

↓

Ascending or perinatal exposure

↓

Premature/newborn infant

↓

Respiratory or disseminated infection

→ Consider Ureaplasma

Diagnosis

The source lists:

• Culture on special media

• Serologic testing

• PCR

Special Culture Requirements

Routine bacterial culture may fail to detect Ureaplasma.

The organism requires:

SPECIALIZED CULTURE MEDIA

Because it hydrolyzes urea, appropriate specialized media can help identify its characteristic metabolic activity.

Gram Stain

Routine Gram staining is not particularly useful because:

THERE IS NO CELL WALL

Therefore, the organism does not produce the conventional Gram-staining appearance expected from typical bacteria.

PCR

Molecular testing using:

PCR/NAAT

can detect Ureaplasma nucleic acid and may be particularly useful when routine cultures are negative or specialized culture is unavailable.

Interpretation still requires clinical context because:

Colonization is common.

Treatment

The source recommends:

MACROLIDE ANTIBIOTIC

for approximately:

7–14 days

depending on the clinical syndrome.

Additional Treatment

The source lists:

• Doxycycline

• Ofloxacin

as additional treatment options.

Antimicrobial selection should account for:

Patient population, infection site, pregnancy status, local resistance, and susceptibility when available.

Ciprofloxacin Resistance

The source specifically warns against:

CIPROFLOXACIN

because a substantial proportion of U. urealyticum isolates may be resistant.

Resistance patterns vary geographically and over time, so susceptibility and current clinical guidance are important for serious infections.

β-Lactam Resistance

Unlike acquired resistance, resistance to β-lactams is a direct consequence of the organism’s biology.

Because Ureaplasma has:

NO CELL WALL

it is intrinsically resistant to drugs targeting:

Peptidoglycan synthesis

High-Yield Treatment Rule

NO WALL = NO β-LACTAMS

Think:

Penicillin ✗

Cephalosporin ✗

Macrolide ✓

Doxycycline ✓

Ureaplasma vs. Mycoplasma

Both organisms:

• Are extremely small

• Lack cell walls

• Are pleomorphic

• Do not respond to β-lactams

• Require specialized diagnostic approaches

However:

Ureaplasma

→ Hydrolyzes urea

→ Strong genitourinary association

→ Urethritis

→ Chorioamnionitis

→ Neonatal disease

Mycoplasma pneumoniae

→ Primarily respiratory

→ Atypical “walking” pneumonia

→ May be associated with cold agglutinins

Ureaplasma vs. Mycoplasma genitalium

Both may be associated with:

Nongonococcal urethritis

Ureaplasma urealyticum

→ Frequently colonizes GU tract

→ Pathogenic significance may depend on clinical context and organism burden

Mycoplasma genitalium

→ Established sexually transmitted cause of persistent/recurrent NGU

→ Also associated with cervicitis and PID

→ Antimicrobial resistance is a major treatment issue

Ureaplasma vs. Chlamydia trachomatis

Both can be associated with:

Nongonococcal urethritis

Ureaplasma

→ No cell wall

→ Urease positive

→ β-lactams ineffective

→ Specialized culture/PCR

Chlamydia trachomatis

→ Obligate intracellular organism

→ Elementary and reticulate body life cycle

→ Major established cause of NGU and cervicitis

High-Yield Clinical Pattern

Nongonococcal urethritis

• ●

Very small pleomorphic bacterium

• ●

No cell wall

• ●

Urea hydrolysis

• ●

β-lactam resistance

→ Think UREAPLASMA UREALYTICUM

High-Yield Pregnancy Pattern

Genital colonization

• ●

Pregnancy

• ●

Chorioamnionitis

• ●

Premature or infected newborn

→ Consider UREAPLASMA

Exam Essentials

Genus: Ureaplasma

Species: U. urealyticum and U. parvum

Organism: Very small bacterium

Cell wall: Absent

Gram stain: Poorly visualized/not conventionally Gram stained

Important metabolic feature: Urease activity

Distribution: Worldwide

Colonization: Common in the genitourinary tract

NGU incubation in source: 10–20 days

Major adult infection: Nongonococcal urethritis

Pregnancy association: Chorioamnionitis

Neonatal disease: Respiratory and potentially disseminated infection

Diagnosis: Special culture media + molecular testing/PCR

Source treatment: Macrolide for 7–14 days

Additional source treatment: Doxycycline or ofloxacin

Important resistance concept: β-lactams are intrinsically ineffective because there is no cell wall

Ciprofloxacin: Source notes substantial resistance

Memory Aid

UREAPLASMA = UREA + NO WALL

Think:

UREA

→ Urease

PLASMA

→ Tiny cell-wall-deficient organism

And remember:

NO WALL → NO PENICILLIN

Classic Exam Pattern

Sexually active patient

• ●

Nongonococcal urethritis

• ●

Organism lacks cell wall

• ●

Urease positive

→ Ureaplasma urealyticum

Key clinical pearl: Ureaplasma urealyticum and U. parvum are very small, cell-wall-deficient bacteria that commonly colonize the genitourinary tract. They are associated with nongonococcal urethritis, chorioamnionitis, and neonatal infection. Their absence of a peptidoglycan cell wall makes β-lactam antibiotics intrinsically ineffective, while their ability to hydrolyze urea is a characteristic microbiologic clue.